PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-33.55%
Revenue decline while VET shows 34.94% growth. Joel Greenblatt would examine competitive position erosion.
-17.66%
Cost reduction while VET shows 18.51% growth. Joel Greenblatt would examine competitive advantage.
-48.52%
Gross profit decline while VET shows 54.88% growth. Joel Greenblatt would examine competitive position.
-22.54%
Margin decline while VET shows 14.77% expansion. Joel Greenblatt would examine competitive position.
No Data
No Data available this quarter, please select a different quarter.
-6.80%
G&A reduction while VET shows 2.69% growth. Joel Greenblatt would examine efficiency advantage.
No Data
No Data available this quarter, please select a different quarter.
-300.00%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
-1.47%
Operating expenses reduction while VET shows 17.39% growth. Joel Greenblatt would examine advantage.
-9.52%
Total costs reduction while VET shows 17.99% growth. Joel Greenblatt would examine advantage.
122.40%
Interest expense growth above 1.5x VET's 9.41%. Michael Burry would check for over-leverage.
-15.45%
D&A reduction while VET shows 22.20% growth. Joel Greenblatt would examine efficiency.
-30.78%
EBITDA decline while VET shows 43.94% growth. Joel Greenblatt would examine position.
4.16%
EBITDA margin growth while VET declines. John Neff would investigate advantages.
-1010.00%
Operating income decline while VET shows 1032.04% growth. Joel Greenblatt would examine position.
-1469.39%
Operating margin decline while VET shows 790.69% growth. Joel Greenblatt would examine position.
15.24%
Other expenses growth less than half of VET's 94.57%. David Dodd would verify if advantage is sustainable.
3.99%
Pre-tax income growth below 50% of VET's 101558.33%. Michael Burry would check for structural issues.
-44.47%
Pre-tax margin decline while VET shows 75234.85% growth. Joel Greenblatt would examine position.
0.95%
Tax expense growth less than half of VET's 1505.68%. David Dodd would verify if advantage is sustainable.
5.68%
Net income growth below 50% of VET's 434.35%. Michael Burry would check for structural issues.
-41.93%
Net margin decline while VET shows 295.99% growth. Joel Greenblatt would examine position.
15.01%
EPS growth below 50% of VET's 500.00%. Michael Burry would check for structural issues.
15.01%
Diluted EPS growth below 50% of VET's 500.00%. Michael Burry would check for structural issues.
11.01%
Share count reduction below 50% of VET's 1.68%. Michael Burry would check for concerns.
11.01%
Diluted share reduction below 50% of VET's 1.32%. Michael Burry would check for concerns.